Table of Content

1 Diabetes Drugs Market Overview
1.1 Diabetes Drugs Product Overview
1.2 Diabetes Drugs Market Segment by Type
1.2.1 Insulin
1.2.2 DPP-4
1.2.3 GLP-1
1.2.4 SGLT-2
1.3 Global Diabetes Drugs Market Size by Type
1.3.1 Global Diabetes Drugs Market Size Overview by Type (2018-2034)
1.3.2 Global Diabetes Drugs Historic Market Size Review by Type (2018-2024)
1.3.3 Global Diabetes Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Diabetes Drugs Sales Breakdown by Type (2018-2024)
1.4.2 Europe Diabetes Drugs Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Diabetes Drugs Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Diabetes Drugs Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Diabetes Drugs Sales Breakdown by Type (2018-2024)
2 Global Diabetes Drugs Market Competition by Company
2.1 Global Top Players by Diabetes Drugs Sales (2018-2024)
2.2 Global Top Players by Diabetes Drugs Revenue (2018-2024)
2.3 Global Top Players by Diabetes Drugs Price (2018-2024)
2.4 Global Top Manufacturers Diabetes Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Diabetes Drugs Market Competitive Situation and Trends
2.5.1 Diabetes Drugs Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Diabetes Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Diabetes Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Diabetes Drugs Market
2.8 Key Manufacturers Diabetes Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Diabetes Drugs Status and Outlook by Region
3.1 Global Diabetes Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Diabetes Drugs Historic Market Size by Region
3.2.1 Global Diabetes Drugs Sales in Volume by Region (2018-2024)
3.2.2 Global Diabetes Drugs Sales in Value by Region (2018-2024)
3.2.3 Global Diabetes Drugs Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Diabetes Drugs Forecasted Market Size by Region
3.3.1 Global Diabetes Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global Diabetes Drugs Sales in Value by Region (2024-2034)
3.3.3 Global Diabetes Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Diabetes Drugs by Application
4.1 Diabetes Drugs Market Segment by Application
4.1.1 Type 1 Diabetes
4.1.2 Type 2 Diabetes
4.2 Global Diabetes Drugs Market Size by Application
4.2.1 Global Diabetes Drugs Market Size Overview by Application (2018-2034)
4.2.2 Global Diabetes Drugs Historic Market Size Review by Application (2018-2024)
4.2.3 Global Diabetes Drugs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Diabetes Drugs Sales Breakdown by Application (2018-2024)
4.3.2 Europe Diabetes Drugs Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Diabetes Drugs Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Diabetes Drugs Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Diabetes Drugs Sales Breakdown by Application (2018-2024)
5 North America Diabetes Drugs by Country
5.1 North America Diabetes Drugs Historic Market Size by Country
5.1.1 North America Diabetes Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Diabetes Drugs Sales in Volume by Country (2018-2024)
5.1.3 North America Diabetes Drugs Sales in Value by Country (2018-2024)
5.2 North America Diabetes Drugs Forecasted Market Size by Country
5.2.1 North America Diabetes Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America Diabetes Drugs Sales in Value by Country (2024-2034)
6 Europe Diabetes Drugs by Country
6.1 Europe Diabetes Drugs Historic Market Size by Country
6.1.1 Europe Diabetes Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Diabetes Drugs Sales in Volume by Country (2018-2024)
6.1.3 Europe Diabetes Drugs Sales in Value by Country (2018-2024)
6.2 Europe Diabetes Drugs Forecasted Market Size by Country
6.2.1 Europe Diabetes Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe Diabetes Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific Diabetes Drugs by Region
7.1 Asia-Pacific Diabetes Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Diabetes Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Diabetes Drugs Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Diabetes Drugs Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Diabetes Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Diabetes Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Diabetes Drugs Sales in Value by Region (2024-2034)
8 Latin America Diabetes Drugs by Country
8.1 Latin America Diabetes Drugs Historic Market Size by Country
8.1.1 Latin America Diabetes Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Diabetes Drugs Sales in Volume by Country (2018-2024)
8.1.3 Latin America Diabetes Drugs Sales in Value by Country (2018-2024)
8.2 Latin America Diabetes Drugs Forecasted Market Size by Country
8.2.1 Latin America Diabetes Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America Diabetes Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa Diabetes Drugs by Country
9.1 Middle East and Africa Diabetes Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Diabetes Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Diabetes Drugs Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Diabetes Drugs Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Diabetes Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Diabetes Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Diabetes Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Sanofi
10.1.1 Sanofi Company Information
10.1.2 Sanofi Introduction and Business Overview
10.1.3 Sanofi Diabetes Drugs Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Sanofi Diabetes Drugs Products Offered
10.1.5 Sanofi Recent Development
10.2 AstraZeneca
10.2.1 AstraZeneca Company Information
10.2.2 AstraZeneca Introduction and Business Overview
10.2.3 AstraZeneca Diabetes Drugs Sales, Revenue and Gross Margin (2018-2024)
10.2.4 AstraZeneca Diabetes Drugs Products Offered
10.2.5 AstraZeneca Recent Development
10.3 Bayer
10.3.1 Bayer Company Information
10.3.2 Bayer Introduction and Business Overview
10.3.3 Bayer Diabetes Drugs Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Bayer Diabetes Drugs Products Offered
10.3.5 Bayer Recent Development
10.4 Biocon
10.4.1 Biocon Company Information
10.4.2 Biocon Introduction and Business Overview
10.4.3 Biocon Diabetes Drugs Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Biocon Diabetes Drugs Products Offered
10.4.5 Biocon Recent Development
10.5 Boehringer Ingelheim
10.5.1 Boehringer Ingelheim Company Information
10.5.2 Boehringer Ingelheim Introduction and Business Overview
10.5.3 Boehringer Ingelheim Diabetes Drugs Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Boehringer Ingelheim Diabetes Drugs Products Offered
10.5.5 Boehringer Ingelheim Recent Development
10.6 Dongbao Pharmaceutical
10.6.1 Dongbao Pharmaceutical Company Information
10.6.2 Dongbao Pharmaceutical Introduction and Business Overview
10.6.3 Dongbao Pharmaceutical Diabetes Drugs Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Dongbao Pharmaceutical Diabetes Drugs Products Offered
10.6.5 Dongbao Pharmaceutical Recent Development
10.7 Eli Lilly
10.7.1 Eli Lilly Company Information
10.7.2 Eli Lilly Introduction and Business Overview
10.7.3 Eli Lilly Diabetes Drugs Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Eli Lilly Diabetes Drugs Products Offered
10.7.5 Eli Lilly Recent Development
10.8 Ganlee
10.8.1 Ganlee Company Information
10.8.2 Ganlee Introduction and Business Overview
10.8.3 Ganlee Diabetes Drugs Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Ganlee Diabetes Drugs Products Offered
10.8.5 Ganlee Recent Development
10.9 Ginwa
10.9.1 Ginwa Company Information
10.9.2 Ginwa Introduction and Business Overview
10.9.3 Ginwa Diabetes Drugs Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Ginwa Diabetes Drugs Products Offered
10.9.5 Ginwa Recent Development
10.10 Guangzhou Baiyun Mountain
10.10.1 Guangzhou Baiyun Mountain Company Information
10.10.2 Guangzhou Baiyun Mountain Introduction and Business Overview
10.10.3 Guangzhou Baiyun Mountain Diabetes Drugs Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Guangzhou Baiyun Mountain Diabetes Drugs Products Offered
10.10.5 Guangzhou Baiyun Mountain Recent Development
10.11 Hisun Pharmacy
10.11.1 Hisun Pharmacy Company Information
10.11.2 Hisun Pharmacy Introduction and Business Overview
10.11.3 Hisun Pharmacy Diabetes Drugs Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Hisun Pharmacy Diabetes Drugs Products Offered
10.11.5 Hisun Pharmacy Recent Development
10.12 Hua Dong
10.12.1 Hua Dong Company Information
10.12.2 Hua Dong Introduction and Business Overview
10.12.3 Hua Dong Diabetes Drugs Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Hua Dong Diabetes Drugs Products Offered
10.12.5 Hua Dong Recent Development
10.13 Huadong Medicine
10.13.1 Huadong Medicine Company Information
10.13.2 Huadong Medicine Introduction and Business Overview
10.13.3 Huadong Medicine Diabetes Drugs Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Huadong Medicine Diabetes Drugs Products Offered
10.13.5 Huadong Medicine Recent Development
10.14 Jumpcan Pharmacy
10.14.1 Jumpcan Pharmacy Company Information
10.14.2 Jumpcan Pharmacy Introduction and Business Overview
10.14.3 Jumpcan Pharmacy Diabetes Drugs Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Jumpcan Pharmacy Diabetes Drugs Products Offered
10.14.5 Jumpcan Pharmacy Recent Development
10.15 KELUN
10.15.1 KELUN Company Information
10.15.2 KELUN Introduction and Business Overview
10.15.3 KELUN Diabetes Drugs Sales, Revenue and Gross Margin (2018-2024)
10.15.4 KELUN Diabetes Drugs Products Offered
10.15.5 KELUN Recent Development
10.16 Merck & Co.
10.16.1 Merck & Co. Company Information
10.16.2 Merck & Co. Introduction and Business Overview
10.16.3 Merck & Co. Diabetes Drugs Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Merck & Co. Diabetes Drugs Products Offered
10.16.5 Merck & Co. Recent Development
10.17 MSD
10.17.1 MSD Company Information
10.17.2 MSD Introduction and Business Overview
10.17.3 MSD Diabetes Drugs Sales, Revenue and Gross Margin (2018-2024)
10.17.4 MSD Diabetes Drugs Products Offered
10.17.5 MSD Recent Development
10.18 North China Pharmaceutical Group Corporation
10.18.1 North China Pharmaceutical Group Corporation Company Information
10.18.2 North China Pharmaceutical Group Corporation Introduction and Business Overview
10.18.3 North China Pharmaceutical Group Corporation Diabetes Drugs Sales, Revenue and Gross Margin (2018-2024)
10.18.4 North China Pharmaceutical Group Corporation Diabetes Drugs Products Offered
10.18.5 North China Pharmaceutical Group Corporation Recent Development
10.19 Novartis
10.19.1 Novartis Company Information
10.19.2 Novartis Introduction and Business Overview
10.19.3 Novartis Diabetes Drugs Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Novartis Diabetes Drugs Products Offered
10.19.5 Novartis Recent Development
10.20 Novo Nordisk
10.20.1 Novo Nordisk Company Information
10.20.2 Novo Nordisk Introduction and Business Overview
10.20.3 Novo Nordisk Diabetes Drugs Sales, Revenue and Gross Margin (2018-2024)
10.20.4 Novo Nordisk Diabetes Drugs Products Offered
10.20.5 Novo Nordisk Recent Development
10.21 Sanofi
10.21.1 Sanofi Company Information
10.21.2 Sanofi Introduction and Business Overview
10.21.3 Sanofi Diabetes Drugs Sales, Revenue and Gross Margin (2018-2024)
10.21.4 Sanofi Diabetes Drugs Products Offered
10.21.5 Sanofi Recent Development
10.22 SHIJIAZHUANG YILING PHARMACEUTICAL
10.22.1 SHIJIAZHUANG YILING PHARMACEUTICAL Company Information
10.22.2 SHIJIAZHUANG YILING PHARMACEUTICAL Introduction and Business Overview
10.22.3 SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Sales, Revenue and Gross Margin (2018-2024)
10.22.4 SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Products Offered
10.22.5 SHIJIAZHUANG YILING PHARMACEUTICAL Recent Development
10.23 Takeda
10.23.1 Takeda Company Information
10.23.2 Takeda Introduction and Business Overview
10.23.3 Takeda Diabetes Drugs Sales, Revenue and Gross Margin (2018-2024)
10.23.4 Takeda Diabetes Drugs Products Offered
10.23.5 Takeda Recent Development
10.24 Taloph
10.24.1 Taloph Company Information
10.24.2 Taloph Introduction and Business Overview
10.24.3 Taloph Diabetes Drugs Sales, Revenue and Gross Margin (2018-2024)
10.24.4 Taloph Diabetes Drugs Products Offered
10.24.5 Taloph Recent Development
10.25 Tianan Pharmaceutical
10.25.1 Tianan Pharmaceutical Company Information
10.25.2 Tianan Pharmaceutical Introduction and Business Overview
10.25.3 Tianan Pharmaceutical Diabetes Drugs Sales, Revenue and Gross Margin (2018-2024)
10.25.4 Tianan Pharmaceutical Diabetes Drugs Products Offered
10.25.5 Tianan Pharmaceutical Recent Development
10.26 Tonghua DongBao
10.26.1 Tonghua DongBao Company Information
10.26.2 Tonghua DongBao Introduction and Business Overview
10.26.3 Tonghua DongBao Diabetes Drugs Sales, Revenue and Gross Margin (2018-2024)
10.26.4 Tonghua DongBao Diabetes Drugs Products Offered
10.26.5 Tonghua DongBao Recent Development
10.27 Wanbang Biopharmaceuticals
10.27.1 Wanbang Biopharmaceuticals Company Information
10.27.2 Wanbang Biopharmaceuticals Introduction and Business Overview
10.27.3 Wanbang Biopharmaceuticals Diabetes Drugs Sales, Revenue and Gross Margin (2018-2024)
10.27.4 Wanbang Biopharmaceuticals Diabetes Drugs Products Offered
10.27.5 Wanbang Biopharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Diabetes Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Diabetes Drugs Industrial Chain Analysis
11.4 Diabetes Drugs Market Dynamics
11.4.1 Diabetes Drugs Industry Trends
11.4.2 Diabetes Drugs Market Drivers
11.4.3 Diabetes Drugs Market Challenges
11.4.4 Diabetes Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Diabetes Drugs Distributors
12.3 Diabetes Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Insulin
Table 2. Major Company of DPP-4
Table 3. Major Company of GLP-1
Table 4. Major Company of SGLT-2
Table 5. Global Diabetes Drugs Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Diabetes Drugs Sales by Type (2018-2024) & (M Units)
Table 7. Global Diabetes Drugs Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Diabetes Drugs Sales by Type (2018-2024) & (US& Million)
Table 9. Global Diabetes Drugs Market Share in Value by Type (2018-2024)
Table 10. Global Diabetes Drugs Price by Type (2018-2024) & (USD/Unit)
Table 11. Global Diabetes Drugs Sales by Type (2024-2034) & (M Units)
Table 12. Global Diabetes Drugs Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Diabetes Drugs Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Diabetes Drugs Sales Market Share in Value by Type (2024-2034)
Table 15. Global Diabetes Drugs Price by Type (2024-2034) & (USD/Unit)
Table 16. North America Diabetes Drugs Sales by Type (2018-2024) & (M Units)
Table 17. North America Diabetes Drugs Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Diabetes Drugs Sales (M Units) by Type (2018-2024)
Table 19. Europe Diabetes Drugs Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Diabetes Drugs Sales (M Units) by Type (2018-2024)
Table 21. Asia-Pacific Diabetes Drugs Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Diabetes Drugs Sales (M Units) by Type (2018-2024)
Table 23. Latin America Diabetes Drugs Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Diabetes Drugs Sales (M Units) by Type (2018-2024)
Table 25. Middle East and Africa Diabetes Drugs Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Diabetes Drugs Sales by Company (2018-2024) & (M Units)
Table 27. Global Diabetes Drugs Sales Share by Company (2018-2024)
Table 28. Global Diabetes Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Diabetes Drugs Revenue Share by Company (2018-2024)
Table 30. Global Market Diabetes Drugs Price by Company (2018-2024) & (USD/Unit)
Table 31. Global Diabetes Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Diabetes Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Diabetes Drugs as of 2022)
Table 34. Date of Key Manufacturers Enter into Diabetes Drugs Market
Table 35. Key Manufacturers Diabetes Drugs Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Diabetes Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Diabetes Drugs Sales by Region (2018-2024) & (M Units)
Table 39. Global Diabetes Drugs Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Diabetes Drugs Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Diabetes Drugs Sales Market Share in Value by Region (2018-2024)
Table 42. Global Diabetes Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 43. Global Diabetes Drugs Sales by Region (2024-2034) & (M Units)
Table 44. Global Diabetes Drugs Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Diabetes Drugs Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Diabetes Drugs Sales Market Share in Value by Region (2024-2034)
Table 47. Global Diabetes Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 48. Global Diabetes Drugs Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Diabetes Drugs Sales by Application (2018-2024) & (M Units)
Table 50. Global Diabetes Drugs Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Diabetes Drugs Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Diabetes Drugs Sales Market Share in Value by Application (2018-2024)
Table 53. Global Diabetes Drugs Price by Application (2018-2024) & (USD/Unit)
Table 54. Global Diabetes Drugs Sales by Application (2024-2034) & (M Units)
Table 55. Global Diabetes Drugs Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Diabetes Drugs Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Diabetes Drugs Sales Market Share in Value by Application (2024-2034)
Table 58. Global Diabetes Drugs Price by Application (2024-2034) & (USD/Unit)
Table 59. North America Diabetes Drugs Sales by Application (2018-2024) (M Units)
Table 60. North America Diabetes Drugs Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Diabetes Drugs Sales by Application (2018-2024) (M Units)
Table 62. Europe Diabetes Drugs Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Diabetes Drugs Sales by Application (2018-2024) (M Units)
Table 64. Asia-Pacific Diabetes Drugs Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Diabetes Drugs Sales by Application (2018-2024) (M Units)
Table 66. Latin America Diabetes Drugs Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Diabetes Drugs Sales by Application (2018-2024) (M Units)
Table 68. Middle East and Africa Diabetes Drugs Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Diabetes Drugs Sales by Country (2018-2024) & (M Units)
Table 70. North America Diabetes Drugs Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Diabetes Drugs Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Diabetes Drugs Sales Market Share in Value by Country (2018-2024)
Table 73. North America Diabetes Drugs Sales by Country (2024-2034) & (M Units)
Table 74. North America Diabetes Drugs Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Diabetes Drugs Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Diabetes Drugs Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Diabetes Drugs Sales by Country (2018-2024) & (M Units)
Table 78. Europe Diabetes Drugs Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Diabetes Drugs Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Diabetes Drugs Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Diabetes Drugs Sales by Country (2024-2034) & (M Units)
Table 82. Europe Diabetes Drugs Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Diabetes Drugs Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Diabetes Drugs Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Diabetes Drugs Sales by Region (2018-2024) & (M Units)
Table 86. Asia-Pacific Diabetes Drugs Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Diabetes Drugs Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Diabetes Drugs Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Diabetes Drugs Sales by Region (2024-2034) & (M Units)
Table 90. Asia-Pacific Diabetes Drugs Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Diabetes Drugs Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Diabetes Drugs Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Diabetes Drugs Sales by Country (2018-2024) & (M Units)
Table 94. Latin America Diabetes Drugs Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Diabetes Drugs Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Diabetes Drugs Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Diabetes Drugs Sales by Country (2024-2034) & (M Units)
Table 98. Latin America Diabetes Drugs Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Diabetes Drugs Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Diabetes Drugs Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Diabetes Drugs Sales by Country (2018-2024) & (M Units)
Table 102. Middle East and Africa Diabetes Drugs Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Diabetes Drugs Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Diabetes Drugs Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Diabetes Drugs Sales by Country (2024-2034) & (M Units)
Table 106. Middle East and Africa Diabetes Drugs Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Diabetes Drugs Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Diabetes Drugs Sales Market Share in Value by Country (2024-2034)
Table 109. Sanofi Company Information
Table 110. Sanofi Introduction and Business Overview
Table 111. Sanofi Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 112. Sanofi Diabetes Drugs Product
Table 113. Sanofi Recent Development
Table 114. AstraZeneca Company Information
Table 115. AstraZeneca Introduction and Business Overview
Table 116. AstraZeneca Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 117. AstraZeneca Diabetes Drugs Product
Table 118. AstraZeneca Recent Development
Table 119. Bayer Company Information
Table 120. Bayer Introduction and Business Overview
Table 121. Bayer Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 122. Bayer Diabetes Drugs Product
Table 123. Bayer Recent Development
Table 124. Biocon Company Information
Table 125. Biocon Introduction and Business Overview
Table 126. Biocon Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 127. Biocon Diabetes Drugs Product
Table 128. Biocon Recent Development
Table 129. Boehringer Ingelheim Company Information
Table 130. Boehringer Ingelheim Introduction and Business Overview
Table 131. Boehringer Ingelheim Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 132. Boehringer Ingelheim Diabetes Drugs Product
Table 133. Boehringer Ingelheim Recent Development
Table 134. Dongbao Pharmaceutical Company Information
Table 135. Dongbao Pharmaceutical Introduction and Business Overview
Table 136. Dongbao Pharmaceutical Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 137. Dongbao Pharmaceutical Diabetes Drugs Product
Table 138. Dongbao Pharmaceutical Recent Development
Table 139. Eli Lilly Company Information
Table 140. Eli Lilly Introduction and Business Overview
Table 141. Eli Lilly Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 142. Eli Lilly Diabetes Drugs Product
Table 143. Eli Lilly Recent Development
Table 144. Ganlee Company Information
Table 145. Ganlee Introduction and Business Overview
Table 146. Ganlee Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 147. Ganlee Diabetes Drugs Product
Table 148. Ganlee Recent Development
Table 149. Ginwa Company Information
Table 150. Ginwa Introduction and Business Overview
Table 151. Ginwa Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 152. Ginwa Diabetes Drugs Product
Table 153. Ginwa Recent Development
Table 154. Guangzhou Baiyun Mountain Company Information
Table 155. Guangzhou Baiyun Mountain Introduction and Business Overview
Table 156. Guangzhou Baiyun Mountain Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 157. Guangzhou Baiyun Mountain Diabetes Drugs Product
Table 158. Guangzhou Baiyun Mountain Recent Development
Table 159. Hisun Pharmacy Company Information
Table 160. Hisun Pharmacy Introduction and Business Overview
Table 161. Hisun Pharmacy Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 162. Hisun Pharmacy Diabetes Drugs Product
Table 163. Hisun Pharmacy Recent Development
Table 164. Hua Dong Company Information
Table 165. Hua Dong Introduction and Business Overview
Table 166. Hua Dong Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 167. Hua Dong Diabetes Drugs Product
Table 168. Hua Dong Recent Development
Table 169. Huadong Medicine Company Information
Table 170. Huadong Medicine Introduction and Business Overview
Table 171. Huadong Medicine Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 172. Huadong Medicine Diabetes Drugs Product
Table 173. Huadong Medicine Recent Development
Table 174. Jumpcan Pharmacy Company Information
Table 175. Jumpcan Pharmacy Introduction and Business Overview
Table 176. Jumpcan Pharmacy Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 177. Jumpcan Pharmacy Diabetes Drugs Product
Table 178. Jumpcan Pharmacy Recent Development
Table 179. KELUN Company Information
Table 180. KELUN Introduction and Business Overview
Table 181. KELUN Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 182. KELUN Diabetes Drugs Product
Table 183. KELUN Recent Development
Table 184. Merck & Co. Company Information
Table 185. Merck & Co. Introduction and Business Overview
Table 186. Merck & Co. Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 187. Merck & Co. Diabetes Drugs Product
Table 188. Merck & Co. Recent Development
Table 189. MSD Company Information
Table 190. MSD Introduction and Business Overview
Table 191. MSD Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 192. MSD Diabetes Drugs Product
Table 193. MSD Recent Development
Table 194. North China Pharmaceutical Group Corporation Company Information
Table 195. North China Pharmaceutical Group Corporation Introduction and Business Overview
Table 196. North China Pharmaceutical Group Corporation Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 197. North China Pharmaceutical Group Corporation Diabetes Drugs Product
Table 198. North China Pharmaceutical Group Corporation Recent Development
Table 199. Novartis Company Information
Table 200. Novartis Introduction and Business Overview
Table 201. Novartis Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 202. Novartis Diabetes Drugs Product
Table 203. Novartis Recent Development
Table 204. Novo Nordisk Company Information
Table 205. Novo Nordisk Introduction and Business Overview
Table 206. Novo Nordisk Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 207. Novo Nordisk Diabetes Drugs Product
Table 208. Novo Nordisk Recent Development
Table 209. Sanofi Company Information
Table 210. Sanofi Introduction and Business Overview
Table 211. Sanofi Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 212. Sanofi Diabetes Drugs Product
Table 213. Sanofi Recent Development
Table 214. SHIJIAZHUANG YILING PHARMACEUTICAL Company Information
Table 215. SHIJIAZHUANG YILING PHARMACEUTICAL Introduction and Business Overview
Table 216. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 217. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Product
Table 218. SHIJIAZHUANG YILING PHARMACEUTICAL Recent Development
Table 219. Takeda Company Information
Table 220. Takeda Introduction and Business Overview
Table 221. Takeda Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 222. Takeda Diabetes Drugs Product
Table 223. Takeda Recent Development
Table 224. Taloph Company Information
Table 225. Taloph Introduction and Business Overview
Table 226. Taloph Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 227. Taloph Diabetes Drugs Product
Table 228. Taloph Recent Development
Table 229. Tianan Pharmaceutical Introduction and Business Overview
Table 230. Tianan Pharmaceutical Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 231. Tianan Pharmaceutical Diabetes Drugs Product
Table 232. Tianan Pharmaceutical Recent Development
Table 233. Tianan Pharmaceutical Company Information
Table 234. Tonghua DongBao Company Information
Table 235. Tonghua DongBao Introduction and Business Overview
Table 236. Tonghua DongBao Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 237. Tonghua DongBao Diabetes Drugs Product
Table 238. Tonghua DongBao Recent Development
Table 239. Wanbang Biopharmaceuticals Company Information
Table 240. Wanbang Biopharmaceuticals Introduction and Business Overview
Table 241. Wanbang Biopharmaceuticals Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 242. Wanbang Biopharmaceuticals Diabetes Drugs Product
Table 243. Wanbang Biopharmaceuticals Recent Development
Table 244. Key Raw Materials Lists
Table 245. Raw Materials Key Suppliers Lists
Table 246. Diabetes Drugs Market Trends
Table 247. Diabetes Drugs Market Drivers
Table 248. Diabetes Drugs Market Challenges
Table 249. Diabetes Drugs Market Restraints
Table 250. Diabetes Drugs Distributors List
Table 251. Diabetes Drugs Downstream Customers
Table 252. Research Programs/Design for This Report
Table 253. Key Data Information from Secondary Sources
Table 254. Key Data Information from Primary Sources
List of Figures
Figure 1. Diabetes Drugs Product Picture
Figure 2. Global Diabetes Drugs Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Diabetes Drugs Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Diabetes Drugs Sales Status and Outlook (2018-2034) & (M Units)
Figure 5. Product Picture of Insulin
Figure 6. Global Insulin Sales YoY Growth (2018-2034) & (M Units)
Figure 7. Product Picture of DPP-4
Figure 8. Global DPP-4 Sales YoY Growth (2018-2034) & (M Units)
Figure 9. Product Picture of GLP-1
Figure 10. Global GLP-1 Sales YoY Growth (2018-2034) & (M Units)
Figure 11. Product Picture of SGLT-2
Figure 12. Global SGLT-2 Sales YoY Growth (2018-2034) & (M Units)
Figure 13. Global Diabetes Drugs Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Diabetes Drugs Sales Market Share by Type in 2022 & 2034
Figure 15. North America Diabetes Drugs Sales Market Share in Volume by Type in 2022
Figure 16. North America Diabetes Drugs Sales Market Share in Value by Type in 2022
Figure 17. Europe Diabetes Drugs Sales Market Share in Volume by Type in 2022
Figure 18. Europe Diabetes Drugs Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Diabetes Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Diabetes Drugs Sales Market Share in Value by Type in 2022
Figure 21. Latin America Diabetes Drugs Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Diabetes Drugs Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Diabetes Drugs Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Diabetes Drugs Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Diabetes Drugs Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Diabetes Drugs Revenue in 2022
Figure 27. Diabetes Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Type 1 Diabetes
Figure 29. Global Type 1 Diabetes Sales YoY Growth (2018-2034) & (M Units)
Figure 30. Product Picture of Type 2 Diabetes
Figure 31. Global Type 2 Diabetes Sales YoY Growth (2018-2034) & (M Units)
Figure 32. Global Diabetes Drugs Sales by Application (2018-2034) & (US$ Million)
Figure 33. Global Diabetes Drugs Sales Market Share by Application in 2022 & 2034
Figure 34. North America Diabetes Drugs Sales Market Share in Volume by Application in 2022
Figure 35. North America Diabetes Drugs Sales Market Share in Value by Application in 2022
Figure 36. Europe Diabetes Drugs Sales Market Share in Volume by Application in 2022
Figure 37. Europe Diabetes Drugs Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Diabetes Drugs Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Diabetes Drugs Sales Market Share in Value by Application in 2022
Figure 40. Latin America Diabetes Drugs Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Diabetes Drugs Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Diabetes Drugs Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Diabetes Drugs Manufacturing Cost Structure
Figure 45. Diabetes Drugs Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed